| | |
PTI 04:12 PM | August 11,2009
With this approval, Ranbaxy has expanded the product portfolio of Sumatriptan tablets as the company had already got the FDA nod to launch the drug in 100 mg strength
|
|
C.H. Unnikrishnan 08:56 PM | August 02,2009
The FDA letter also warns the firm that it can be charged with misbranding
|
|
PTI 09:38 PM | July 02,2009
According to the information available on regulator’s website, the company has got the approval in 100mg/5ml strength
|
|
C.H. Unnikrishnan and Radhieka Pandeya 12:34 AM | June 27,2009
Sun, India’s largest drug maker by market value, has a 76% stake in Caraco
|
|
PTI 03:33 PM | April 22,2009
Caraco said the sales revenue of the affected lots is approximately $3 million
|
|
Bloomberg 01:15 AM | April 21,2009
Cipla dropped 2.98% to close at Rs223 in Mumbai trading, the lowest since 6 April
|
|
PTI 04:38 PM | April 09,2009
The two Indian drug makers believe that they are among the first to file for this product, which may lead to 180 days’ exclusivity for its marketing in the US
|
|
Lison Joseph 12:14 AM | April 06,2009
Bill proposes to put in place a more rigorous inspection procedure; may help make pharma firms more competitive
|
|
Radhieka Pandeya 01:15 AM | March 06,2009
The USFDA said on 25 February that Ranbaxy won’t be allowed to introduce new generic drugs from the Paonta Sahib plant because it falsified data about products’ shelf life
|
|
Radhieka Pandeya and C.H. Unnikrishnan 12:22 AM | February 28,2009
India’s drug industry is concerned this could mean slower drug approvals for other pharma companies
|
|
Kanoko Matsuyama / Bloomberg 01:00 AM | January 06,2009
Shares of India’s largest drug company have lost 66% of their value since Tokyo-based Daiichi Sankyo paid Rs737 a share in October
|
|
AP 12:55 PM | December 24,2008
Coca-Cola said it will respond to the FDA in early January, but currently has no plans to change the label
|
|
Radhieka Pandeya 11:56 PM | December 23,2008
New guidelines require companies to prove that their therapies do not increase cardiovascular risks
|
|
C.H. Unnikrishnan 12:58 AM | November 25,2008
The company had got approval for these clinical studies in 2007; had to wait to recruit patients for trials
|
|
PTI 05:04 PM | November 04,2008
Caraco develops, manufactures, markets and distributes generic and private-label pharmaceuticals to wholesalers, distributors and drugstore chains
|
|